Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Poland
/
Pharmaceuticals & Biotech
Create a narrative
Ryvu Therapeutics
WSE:RVU Community
0
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
Ryvu Therapeutics
Popular
Undervalued
Overvalued
There are no community narratives available.
Your Valuation for
RVU
Ryvu Therapeutics
Your Fair Value
zł
Current Price
zł19.28
3.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-111m
174m
2015
2018
2021
2024
2025
2027
2030
Revenue zł173.5m
Earnings zł21.9m
Advanced
Set as Fair Value